Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau

— Macau is on course to become the first of Everest’s Asian territories to get etrasimod approval — Can provide access to patients in China’s Greater Bay area and rest of Asia SHANGHAI, March 10, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks